Position added successfully to: BOTHELL, Wash. - Immunome, Inc. (NASDAQ:IMNM), a biotechnology firm specializing in the development of cancer
Ketki Saxena is the Editor in Chief at Investing.com. She focuses on financial markets, investment strategies, and economic trends, providing insightful analysis and commentary on current events. Ketki's work has been featured in Investing.com, where she shares her expertise and perspectives on the evolving landscape of finance.